Remove 2025 Remove Labelling Remove Packaging
article thumbnail

Sustainability continues to steer pharmaceutical packaging market

European Pharmaceutical Review

The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 billion in 2025 to approximately $174.45 billion by 2033, according to a study published by Towards Packaging. Specifically, the “high quality of biodegradable and recyclable packaging materials” are driving the market.

article thumbnail

Guidance for medicine packaging under Windsor Framework

European Pharmaceutical Review

The agreement stipulates that certain conditions must be met in the labelling and packaging of these medicinal products. The following new measures are set to be introduced on 1 January 2025. After this date: Under the framework, medicines can have the same packaging and labelling across the UK.

Packaging 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What are the Top Pharma Podcasts in 2025?

Pharma Marketing Network

But with hundreds of shows available, which ones stand out in 2025? In this article, we spotlight the most influential pharma podcasts of 2025 and explain why they’re worth tuning into. In 2025, pharma podcasts are no longer niche. Pharma podcasts have become a cornerstone of professional development in the life sciences.

article thumbnail

Pharmapack Award Winners 2025 redefining pharmaceutical packaging and drug delivery

Pharmafile

Award winners by category DELIVERY AND DEVICE INNOVATION SHL Medical for Elexy reusable electromechanical autoinjector ECO-DESIGN WINNER Huhtamaki for Omnilock Ultra PAPER PACKAGING INNOVATION WINNER Mitsubishi Gas Chemical Company for new OXYCAPT Multilayer Plastic Vial PATIENT-CENTRIC DESIGN WINNER UCB Pharma for Bimzelx 160mg 2ml autoinjectors product (..)

article thumbnail

WuXi STA breaks ground on new Delaware manufacturing facility

European Pharmaceutical Review

The second facility for WuXi STA in the US, Phase I of the new campus will provide formulation development, clinical and commercial drug product manufacturing services for a variety of oral and injectable dosage forms, as well as packaging, labelling, storage and distribution services for clinical trial materials and commercial drug products.

article thumbnail

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

Pharmaceutical Technology

Robert Barrie June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Bayer’s Eylea is a heavyweight of the ophthalmic drug landscape, approved for a range of eye diseases. The biosimilar specialist’s stock has been falling over the past year, though the company did post strong Q1 2025 results earlier this year.

article thumbnail

Tisento’s MELAS treatment receives fast track status from FDA

Pharmaceutical Technology

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is studying the therapy in the global Phase IIb PRIZM trial. Subjects who conclude the trial will be qualified for an open-label extension trial. Credit: Volha_R/Shutterstock. Give your business an edge with our leading industry insights.

FDA 52